deCODE genetics (Nasdaq:DCGN) today
announced that its presentation at the Lehman Brothers Ninth Annual
Global Healthcare Conference will be webcast live. deCODE management
will provide an overview of the company's drug development programs and
business.
The presentation will be delivered at 1:30pm EST/6:30pm GMT on
Wednesday, March 8, 2006, at the Loews Miami Beach Hotel in South
Beach, Florida. The webcast can be accessed through the Investors page
on deCODE's website, www.decode.com.
The webcast will be archived for at least one week through this site.
Those interested in listening should log on a few minutes in advance,
in order to download any software or complete any sign-in that may be
required.
About deCODE
deCODE genetics (Nasdaq:DCGN) is a
biopharmaceutical company applying its discoveries in human genetics to
the development of drugs for common diseases. deCODE is a global leader
in gene discovery - our population approach and resources have
enabled us to isolate key genes contributing to major public health
challenges from cardiovascular disease to cancer, genes that are
providing us with drug targets rooted in the basic biology of disease.
deCODE is also leveraging its expertise in human genetics and
integrated drug discovery and development capabilities to offer
innovative products and services in DNA-based diagnostics,
bioinformatics, genotyping, structural biology, drug discovery and
clinical development. deCODE is delivering on the promise of the new
genetics.SM Visit us on the web at www.decode.com.
